期刊文献+

冠状动脉内支架植入术后再发胸痛原因分析 被引量:6

Analysis of Causes of Relapsed Chest Pain After Coronary Stent Placement
下载PDF
导出
摘要 目的:探讨冠状动脉支架植入术后再发胸痛的原因,并观察导致支架内再狭窄的影响因素。方法:对我院行冠状动脉支架植入术后患者随访,对28例再发胸痛者行冠状动脉造影复查。结果:无狭窄13例,支架内再狭窄者15例。应用Logistic多因素逐步回归分析法,分析两组患者的临床特点及随访期间用药情况与再狭窄的相关性。发现血清胆固醇和脂蛋白Lp(α)水平增高是支架内再狭窄的重要独立危险因素。结论:冠状动脉支架植入术后不稳定心绞痛是支架内再狭窄常见临床表现。必须重视并尽可能消除导致支架内再狭窄的因素,调脂应是重要的治疗措施。 Objective:To analyze the causes of relapsed chest pain and risk factors of restenosis after coronary stenting. Methods, Twenty-eight patients with relapsed chest pain after coronary stenting were followed up by angiography. Results, Thirteen cases showed no stenosis and 15 cases present restenosis. The correlation between clinical characteristics and follow-up medications and restenosis in 2 groups were analyzed by logistic regression. The results revealed that increased level of cholesterol and lipoprotein a was the main risk factor of restenosis. Conclusion, Unstable angina after stenting is an usual manifestation of restenosis. We must pay attention to it and eliminate the risk factors of restenosis. Lowering lipids is an important therapeutic measure.
出处 《内科急危重症杂志》 2006年第3期113-114,145,共3页 Journal of Critical Care In Internal Medicine
关键词 支架内再狭窄 胸痛 危险因素 强化降脂 Restenosis Chest pain Risk factor Intensive lipid lowering
  • 相关文献

参考文献9

  • 1Cenena FA.Stenting stent:alternative strategy for treating instent restenosis.Cather Cardiovasc Diagn,1996,39:3772.
  • 2Hojo Y.Restenosis after translumnal coronary angioplasty:a risk factor.Heart,2000,84:83.
  • 3Iarlykova EI,Kuchkina NV,Vorobeva EI,et al.C-reactive protein as possible early prognostic marker of restenosis development in coronary artery stents.Kardiologiia,2002,42:11.
  • 4高润霖,陈纪林,杨跃进,乔树宾,徐波,姚民,秦学文,姚康宝,李贤,武阳丰.冠状动脉内支架植入术后再狭窄的危险因素和预测[J].中华心血管病杂志,2000,28(6):426-429. 被引量:25
  • 5Klee mann A,Eckert S,von Eckardstein A,et al.Effects of lovastain on progression of non-dilated and dilated coronary segements and on restenosis in patients after PTCA.Eur Heart J,1999,20:1393.
  • 6Koster R,Vieluf D,Kiehn M,et al.Nickel and molybdenum contact allergies in patients with coronary instent restenosis.Lancer 2000,356:1895.
  • 7Laham RJ,Carrozza JP,Berger C,et al.Long-term (4-6years) outcome of Palma-shase stenting placement.J Am Coll Cardiol,1997,30:1428.
  • 8Fang J,Alderman M H.Serum uric acid and cardiovascular mortality.The NHANESI epidemiologic follow-up study.1971-1992,JAMA,283:2404.
  • 9Rypins EB,Mline N,Sarfch IJ,et al.Quantitation and fraction of nutrient hepatic blood flow in normal persons,in persons with portal hepertensive cirrhosis,and small diameter portacaval H grafts.Surgery,1988,104:335.

二级参考文献1

共引文献24

同被引文献56

  • 1王林,张金钟,黄体钢.冠心病支架术后再狭窄的综合解析[J].医学与哲学,2005,26(7):27-29. 被引量:1
  • 2余园媛,王伯初,彭亮,王晶波,曾辰.黄连的药理研究进展[J].重庆大学学报(自然科学版),2006,29(2):107-111. 被引量:200
  • 3Moulias A, Alexopoulos D, Long-Term outcome of percutaneous coronary intervention: The significance of native coronary artery disease progression. Clin Cardiol, 2011,10 : 1002.
  • 4Toutouzas K, Colombo A, Stefanadis C. Inflammation and rest enosis after percutaneous coronary interventions. Eur Heart J, 2004,25 : 1679.
  • 5Paolicchi A, Emdin M, Passino C, et al. Beta-lipoprotein- andLDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atheroscferosis, 2006,186:80.
  • 6Paolicchi A, Emdin M, Ghliozeni E, et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gammaglutamyl transpeptidase enzyme activity. Circulation, 2004,109 : 1440.
  • 7Targher G, Arcaro G. Non alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis, 2007, 191:235.
  • 8Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol, 2007,27 : 127e33.
  • 9Karp DR, Shimooku K, Lipsky PE. Expression of Gamma-glu- tamyltranspeptidase protects ramos B ceils from oxidation-in- duced cell death. J Biol Chem, 2006,276:3798.
  • 10Lee DH, Jacobs Jr DR, Gross M, et al. Gamma-glutamyhrans-ferase is a predictor of incident diabetes and hypertension:the coronary artery risk development in young adults (CARDIA) study. Clin Chem, 20[)3,49:1358.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部